IL153971A0 - Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity - Google Patents

Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity

Info

Publication number: IL153971A0
Authority: IL; Israel
Prior art keywords: prophylaxis; obesity; treatment; locating; compounds
Prior art date: 2000-07-20

Application number

IL15397101A

Original Assignee

Solvay Pharm Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-20

Filing date

2001-07-12

Publication date

2003-07-31

2001-07-12 Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh

2003-07-31 Publication of IL153971A0 publication Critical patent/IL153971A0/en

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Wood Science & Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Zoology (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Hematology (AREA)
Diabetes (AREA)
Obesity (AREA)
Biotechnology (AREA)
Analytical Chemistry (AREA)
Physics & Mathematics (AREA)
Immunology (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Child & Adolescent Psychology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Investigating Or Analysing Biological Materials (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

IL15397101A 2000-07-20 2001-07-12 Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity IL153971A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10035227A DE10035227A1 (en)	2000-07-20	2000-07-20	Selection and use of lipogenesis inhibitors for the treatment and prevention of obesity
PCT/EP2001/008051 WO2002007821A1 (en)	2000-07-20	2001-07-12	Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity

Publications (1)

Publication Number	Publication Date
IL153971A0 true IL153971A0 (en)	2003-07-31

Family

ID=7649538

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL15397101A IL153971A0 (en)	2000-07-20	2001-07-12	Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity
IL153971A IL153971A (en)	2000-07-20	2003-01-15	Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL153971A IL153971A (en)	2000-07-20	2003-01-15	Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity

Country Status (26)

Country	Link
EP (1)	EP1307262B1 (en)
JP (1)	JP2004504053A (en)
KR (1)	KR100818827B1 (en)
CN (1)	CN1443085B (en)
AR (1)	AR028730A1 (en)
AT (1)	ATE278441T1 (en)
AU (2)	AU7753401A (en)
BR (1)	BR0112547A (en)
CA (1)	CA2416647A1 (en)
CZ (1)	CZ2003156A3 (en)
DE (2)	DE10035227A1 (en)
DZ (1)	DZ3393A1 (en)
ES (1)	ES2230346T3 (en)
HU (1)	HUP0302309A3 (en)
IL (2)	IL153971A0 (en)
MX (1)	MXPA02012907A (en)
NO (1)	NO20030233L (en)
NZ (1)	NZ523960A (en)
PL (1)	PL201165B1 (en)
PT (1)	PT1307262E (en)
RU (1)	RU2268721C2 (en)
SK (1)	SK287607B6 (en)
TR (1)	TR200402670T4 (en)
TW (1)	TWI274157B (en)
UA (1)	UA74588C2 (en)
WO (1)	WO2002007821A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2567166A1 (en)	2004-05-19	2005-11-24	Solvay Pharmaceuticals Gmbh	Medicaments containing n-sulfamoyl-n'-arylpiperazines for the prophylaxis or treatment of obesity and related conditions
MY147767A (en)	2004-06-16	2013-01-31	Janssen Pharmaceutica Nv	Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
CN101754947A (en)	2005-05-20	2010-06-23	詹森药业有限公司	The preparation method of sulfonamide derivative
TW200804393A (en)	2005-11-14	2008-01-16	Solvay Pharm Gmbh	Novel N-sulfamoyl-N'-benzopyranpiperidines for medical use
US8937096B2 (en)	2005-12-19	2015-01-20	Janssen Pharmaceutica Nv	Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US8716231B2 (en)	2005-12-19	2014-05-06	Janssen Pharmaceutica Nv	Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US8492431B2 (en) *	2005-12-19	2013-07-23	Janssen Pharmaceutica, N.V.	Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
US8691867B2 (en)	2005-12-19	2014-04-08	Janssen Pharmaceutica Nv	Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US8497298B2 (en)	2005-12-19	2013-07-30	Janssen Pharmaceutica Nv	Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
TW200812573A (en)	2006-05-19	2008-03-16	Janssen Pharmaceutica Nv	Co-therapy for the treatment of epilepsy and related disorders
PL2106260T3 (en)	2007-01-25	2018-06-29	NAIA Metabolic, Inc.	Insulin sensitisers and methods of treatment
WO2010008776A2 (en)	2008-06-23	2010-01-21	Janssen Pharmaceutica Nv	Disposable patch and reusable sensor assembly for use in medical device localization and mapping systems
US8815939B2 (en)	2008-07-22	2014-08-26	Janssen Pharmaceutica Nv	Substituted sulfamide derivatives
US20150150855A1 (en) *	2012-05-24	2015-06-04	Verva Pharmaceuticals Ltd	Method of improving liver function
CN106770611B (en) *	2016-12-22	2019-01-29	广西师范大学	A method of entering mitochondria for cell in-situ detection small molecule compound
RU2771430C1 (en) *	2021-09-21	2022-05-04	Федеральное государственное бюджетное научное учреждение "Научный центр неврологии" (ФГБНУ НЦН)	Method for the quantitative determination of anticonvulsants in the blood plasma of patients with epilepsy

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4552897A (en) *	1983-02-01	1985-11-12	American Cyanamid Company	Salts of 1-(aminodihalophenyl)-2-aminoethanols and antilipogenic compositions prepared therefrom
US6288095B1 (en) *	1987-09-04	2001-09-11	Beecham Group P.L.C.	Compounds
US4952567A (en) *	1988-05-09	1990-08-28	City Of Hope	Inhibition of lipogenesis
US5126324A (en) *	1990-06-07	1992-06-30	Genentech, Inc.	Method of enhancing growth in patients using combination therapy
ZA932660B (en) *	1992-04-17	1993-10-26	Sankyo Co	Derivatives of adipogenesis inhibitory factor, their preparation and their use
ES2095086T3 (en) *	1992-10-29	1997-02-01	Genentech Inc	METHOD FOR THE TREATMENT AND PREVENTION OF OBESITY.
AU693478B2 (en) *	1994-11-10	1998-07-02	Metabolic Pharmaceuticals Limited	Treatment of obesity
WO1998000130A2 (en) *	1996-06-28	1998-01-08	Ortho Pharmaceutical Corporation	Anticonvulsant sulfamate derivatives useful in treating obesity
US5727570A (en) *	1996-11-14	1998-03-17	Clemens; Anton H.	Method of treating hyperlipidemia in humans
US20030100594A1 (en) *	2001-08-10	2003-05-29	Pharmacia Corporation	Carbonic anhydrase inhibitor

2000
- 2000-07-20 DE DE10035227A patent/DE10035227A1/en not_active Withdrawn
2001
- 2001-06-15 AR ARP010102883A patent/AR028730A1/en unknown
- 2001-07-12 DE DE50104023T patent/DE50104023D1/en not_active Expired - Lifetime
- 2001-07-12 AU AU7753401A patent/AU7753401A/en active Pending
- 2001-07-12 PL PL363518A patent/PL201165B1/en not_active IP Right Cessation
- 2001-07-12 SK SK61-2003A patent/SK287607B6/en not_active IP Right Cessation
- 2001-07-12 BR BR0112547-8A patent/BR0112547A/en not_active Application Discontinuation
- 2001-07-12 AT AT01955345T patent/ATE278441T1/en active
- 2001-07-12 NZ NZ52396001A patent/NZ523960A/en not_active IP Right Cessation
- 2001-07-12 CA CA002416647A patent/CA2416647A1/en not_active Abandoned
- 2001-07-12 WO PCT/EP2001/008051 patent/WO2002007821A1/en not_active Ceased
- 2001-07-12 IL IL15397101A patent/IL153971A0/en unknown
- 2001-07-12 JP JP2002513551A patent/JP2004504053A/en active Pending
- 2001-07-12 AU AU2001277534A patent/AU2001277534B9/en not_active Ceased
- 2001-07-12 HU HU0302309A patent/HUP0302309A3/en unknown
- 2001-07-12 KR KR1020037000620A patent/KR100818827B1/en not_active Expired - Fee Related
- 2001-07-12 ES ES01955345T patent/ES2230346T3/en not_active Expired - Lifetime
- 2001-07-12 CN CN018129730A patent/CN1443085B/en not_active Expired - Fee Related
- 2001-07-12 TR TR2004/02670T patent/TR200402670T4/en unknown
- 2001-07-12 PT PT01955345T patent/PT1307262E/en unknown
- 2001-07-12 MX MXPA02012907A patent/MXPA02012907A/en active IP Right Grant
- 2001-07-12 CZ CZ2003156A patent/CZ2003156A3/en unknown
- 2001-07-12 RU RU2003104803/14A patent/RU2268721C2/en not_active IP Right Cessation
- 2001-07-12 EP EP01955345A patent/EP1307262B1/en not_active Expired - Lifetime
- 2001-07-12 DZ DZ013393A patent/DZ3393A1/en active
- 2001-07-16 TW TW090117382A patent/TWI274157B/en not_active IP Right Cessation
- 2001-12-07 UA UA2003021453A patent/UA74588C2/en unknown
2003
- 2003-01-15 IL IL153971A patent/IL153971A/en not_active IP Right Cessation
- 2003-01-17 NO NO20030233A patent/NO20030233L/en unknown

Also Published As

Publication number	Publication date
EP1307262A1 (en)	2003-05-07
AR028730A1 (en)	2003-05-21
TWI274157B (en)	2007-02-21
CN1443085B (en)	2010-04-28
CA2416647A1 (en)	2003-01-20
BR0112547A (en)	2003-07-01
TR200402670T4 (en)	2004-11-22
WO2002007821A1 (en)	2002-01-31
PL201165B1 (en)	2009-03-31
HK1057499A1 (en)	2004-04-08
JP2004504053A (en)	2004-02-12
CN1443085A (en)	2003-09-17
DE10035227A1 (en)	2002-01-31
NO20030233L (en)	2003-03-19
ES2230346T3 (en)	2005-05-01
HUP0302309A2 (en)	2003-11-28
HUP0302309A3 (en)	2005-06-28
RU2268721C2 (en)	2006-01-27
KR20030022284A (en)	2003-03-15
ATE278441T1 (en)	2004-10-15
AU7753401A (en)	2002-02-05
DE50104023D1 (en)	2004-11-11
MXPA02012907A (en)	2003-09-22
KR100818827B1 (en)	2008-04-01
PT1307262E (en)	2004-12-31
UA74588C2 (en)	2006-01-16
NZ523960A (en)	2004-12-24
AU2001277534B9 (en)	2006-02-23
CZ2003156A3 (en)	2003-06-18
NO20030233D0 (en)	2003-01-17
PL363518A1 (en)	2004-11-29
DZ3393A1 (en)	2002-01-31
EP1307262B1 (en)	2004-10-06
IL153971A (en)	2009-07-20
SK287607B6 (en)	2011-03-04
AU2001277534B2 (en)	2005-09-29
SK612003A3 (en)	2003-06-03

Publication	Publication Date	Title
PL364995A1 (en)	2004-12-27	Method for the treatment or prevention of flavivirus
AU8870701A (en)	2002-03-13	Materials and methods for the treatment or prevention of obesity
PL369237A1 (en)	2005-04-18	Micro-organisms for the treatment of soil and process for obtaining them
GB0014969D0 (en)	2000-08-09	Novel method of treatment
EP1343726A4 (en)	2005-04-13	Processes and compositions for water treatment
HUP0302739A3 (en)	2012-09-28	Method for the treatment of tobacco
EP1337255A4 (en)	2006-01-25	Use of p38 inhibitors for the treatment of inflammation-enhanced cough
IL153971A0 (en)	2003-07-31	Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity
AU2001277534A1 (en)	2002-05-02	Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity
AU2003263760A1 (en)	2004-01-19	Methods for the treatment or prevention of obesity
GB2360035B (en)	2003-08-13	Uv-irradiation device for the treatment of wastewater
AU2002364171A8 (en)	2003-06-30	Materials and methods for the treatment or prevention of obesity
AU7750100A (en)	2001-04-23	Method for the treatment of obesity
PL366404A1 (en)	2005-01-24	Method of treatment
IL155769A0 (en)	2003-12-23	Method for the treatment of inflammation
AU6137801A (en)	2001-11-20	Method and composition for the treatment of angiogenesis
IL144718A0 (en)	2002-06-30	Method and apparatus for the treatment of domestic waste
GB0008921D0 (en)	2000-05-31	Method of treatment
GB0118892D0 (en)	2001-09-26	Method of treatment
AU2002365621A8 (en)	2003-06-17	Composition for treating the surface of the skin
SI1307262T1 (en)	2005-02-28	Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity
IL161630A0 (en)	2004-09-27	Methods of treating endometreosis
GB0027001D0 (en)	2000-12-20	Method and apparatus for the treatment of sludge
GB0001861D0 (en)	2000-03-22	Method for the treatment of obesity
AU2000272704A1 (en)	2002-03-26	Use of compounds for the treatment of obesity